Literature DB >> 17509101

Irritable bowel syndrome: patients' attitudes, concerns and level of knowledge.

B E Lacy1, K Weiser, L Noddin, D J Robertson, M D Crowell, C Parratt-Engstrom, M V Grau.   

Abstract

BACKGROUND: Irritable bowel syndrome (IBS) is a common, chronic disorder that reduces patients' quality-of-life. Although highly prevalent, little is known about patients' understanding of this disorder. AIM: To evaluate the knowledge, fears and concerns of IBS patients.
METHODS: Seven hundred thirty-six IBS patients (Rome II criteria) were eligible for inclusion in this prospective study. Each patient received a validated questionnaire to evaluate knowledge, attitudes and fears regarding IBS.
RESULTS: A total of 261 of 664 potential respondents completed the questionnaire (39.3%). 83% of respondents were women, with a mean age of 53.7 years, and mean duration of symptoms of 14.2 years. Patients frequently believed that IBS develops because of anxiety (80.5%), dietary factors (75.1%) and depression (63.2%). Few respondents (28.7%) recognized that abdominal pain is the cardinal symptom of IBS, and 40.6% stated that colonoscopy can diagnose IBS. One in seven patients stated that IBS turns into cancer, and 29.9% noted that IBS increases the risk of inflammatory bowel disease.
CONCLUSIONS: Many IBS patients have significant misconceptions regarding the nature of their disease and its prognosis. An overwhelming majority of IBS patients believe that anxiety, dietary factors and depression cause IBS. These findings are discordant with physicians' views and practices and highlight the need for patient-oriented educational programs.

Entities:  

Mesh:

Year:  2007        PMID: 17509101     DOI: 10.1111/j.1365-2036.2007.03328.x

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN: 0269-2813            Impact factor:   8.171


  26 in total

1.  Perceived risk as a barrier to appropriate diagnosis of irritable bowel syndrome.

Authors:  Eunmi Ahn; Ki Young Son; Dong Wook Shin; Min Kyu Han; Hyejin Lee; Ah Reum An; Eun Ho Kim; BeLong Cho
Journal:  World J Gastroenterol       Date:  2014-12-28       Impact factor: 5.742

2.  Quality of Care and the Irritable Bowel Syndrome: Is Now the Time to Set Standards?

Authors:  Brian E Lacy; Alexander C Ford; Nicholas J Talley
Journal:  Am J Gastroenterol       Date:  2017-12-05       Impact factor: 10.864

3.  New and Emerging Treatment Options for Irritable Bowel Syndrome.

Authors:  Brian E Lacy; William D Chey; Anthony J Lembo
Journal:  Gastroenterol Hepatol (N Y)       Date:  2015-04

Review 4.  Complementary and alternative medicines in irritable bowel syndrome: an integrative view.

Authors:  Oliver Grundmann; Saunjoo L Yoon
Journal:  World J Gastroenterol       Date:  2014-01-14       Impact factor: 5.742

Review 5.  Complementary and alternative medicine for treatment of irritable bowel syndrome.

Authors:  Yi-Hao A Shen; Richard Nahas
Journal:  Can Fam Physician       Date:  2009-02       Impact factor: 3.275

6.  An Evidence-Based Look at Misconceptions in the Treatment of Patients with IBS-D.

Authors:  Brian E Lacy; William D Chey; Lin Chang
Journal:  Gastroenterol Hepatol (N Y)       Date:  2013-11

Review 7.  Updates on treatment of irritable bowel syndrome.

Authors:  Christopher W Hammerle; Christina M Surawicz
Journal:  World J Gastroenterol       Date:  2008-05-07       Impact factor: 5.742

8.  A Comprehensive Self-Management Irritable Bowel Syndrome Program Produces Sustainable Changes in Behavior After 1 Year.

Authors:  Jasmine K Zia; Pamela Barney; Kevin C Cain; Monica E Jarrett; Margaret M Heitkemper
Journal:  Clin Gastroenterol Hepatol       Date:  2015-11-19       Impact factor: 11.382

9.  Irritable bowel syndrome: the role of food in pathogenesis and management.

Authors:  Paula A Hayes; Marianne H Fraher; Eamonn M M Quigley
Journal:  Gastroenterol Hepatol (N Y)       Date:  2014-03

10.  Editorial: Clinical Implications of Diagnosing Irritable Bowel Syndrome: Do All Roads Need to Lead to Rome?

Authors:  Daniel Keszthelyi; Yehuda Ringel
Journal:  Am J Gastroenterol       Date:  2017-06       Impact factor: 10.864

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.